Chang J, Ramchandra R
Heart Fail Rev. 2024; 30(1):209-218.
PMID: 39438394
PMC: 11646211.
DOI: 10.1007/s10741-024-10456-0.
Inamori T, Kodama K, Tamura Y, Okamatsu H, Sashida Y, Horibata Y
J Cardiol Cases. 2022; 25(1):6-9.
PMID: 35024059
PMC: 8721265.
DOI: 10.1016/j.jccase.2021.05.010.
Perez D
Interv Cardiol (Lond). 2021; 13(6):415-424.
PMID: 34970333
PMC: 8715677.
Dallapellegrina L, Sciatti E, Vizzardi E
Ther Adv Cardiovasc Dis. 2020; 14:1753944720934937.
PMID: 32611276
PMC: 7333483.
DOI: 10.1177/1753944720934937.
Calcagno S, Infusino F, Dettori O, Taccheri T, Bruno P, Maestrini V
Cardiol Res Pract. 2019; 2019:9185876.
PMID: 31061733
PMC: 6466911.
DOI: 10.1155/2019/9185876.
Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently.
Oomman A, Bansal M
Indian Heart J. 2018; 70(2):201-203.
PMID: 29716694
PMC: 5993932.
DOI: 10.1016/j.ihj.2018.03.009.
The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study.
Cacciapuoti F, Magro V, Caturano M, Lama D, Cacciapuoti F
J Cardiovasc Echogr. 2017; 27(4):126-131.
PMID: 29142810
PMC: 5672684.
DOI: 10.4103/jcecho.jcecho_6_17.
Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept.
Meyer M, Rambod M, LeWinter M
Heart Fail Rev. 2017; 23(4):499-506.
PMID: 29098508
PMC: 5934348.
DOI: 10.1007/s10741-017-9660-1.
Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
Tschope C, Birner C, Bohm M, Bruder O, Frantz S, Luchner A
Clin Res Cardiol. 2017; 107(1):1-19.
PMID: 29018938
DOI: 10.1007/s00392-017-1170-6.
Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option?.
Volterrani M, Iellamo F
Card Fail Rev. 2017; 2(2):130-136.
PMID: 28785467
PMC: 5490995.
DOI: 10.15420/cfr.2016:12:1.
Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.
Godino C, Colombo A, Margonato A
Clin Drug Investig. 2016; 37(2):105-120.
PMID: 27766510
DOI: 10.1007/s40261-016-0472-1.
Effectiveness of Ivabradine in Treating Stable Angina Pectoris.
Ye L, Ke D, Chen Q, Li G, Deng W, Wu Z
Medicine (Baltimore). 2016; 95(14):e3245.
PMID: 27057864
PMC: 4998780.
DOI: 10.1097/MD.0000000000003245.
Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study.
Zarifis J, Grammatikou V, Kallistratos M, Katsivas A
Clin Cardiol. 2016; 38(12):725-32.
PMID: 26782939
PMC: 4738471.
DOI: 10.1002/clc.22479.
Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
Tagliamonte E, Cirillo T, Rigo F, Astarita C, Coppola A, Romano C
Adv Ther. 2015; 32(8):757-67.
PMID: 26293212
PMC: 4569671.
DOI: 10.1007/s12325-015-0237-x.
[New therapy concepts for heart failure with preserved ejection fraction].
Tschope C, Pieske B
Herz. 2015; 40(2):194-205.
PMID: 25737289
DOI: 10.1007/s00059-015-4210-x.
Heart failure with preserved ejection fraction.
Gladden J, Linke W, Redfield M
Pflugers Arch. 2014; 466(6):1037-53.
PMID: 24663384
PMC: 4075067.
DOI: 10.1007/s00424-014-1480-8.
Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
Deedwania P
Drugs. 2013; 73(14):1569-86.
PMID: 24065301
PMC: 3786091.
DOI: 10.1007/s40265-013-0117-0.
Heart rate reduction in heart failure: ivabradine or beta blockers?.
Guglin M
Heart Fail Rev. 2012; 18(4):517-28.
PMID: 22972475
DOI: 10.1007/s10741-012-9347-6.
Impaired left ventricular function in the presence of preserved ejection in chronic hypertensive conscious pigs.
Rienzo M, Bize A, Pongas D, Michineau S, Melka J, Chan H
Basic Res Cardiol. 2012; 107(6):298.
PMID: 22961595
PMC: 3980587.
DOI: 10.1007/s00395-012-0298-9.
Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.
Reil J, Hohl M, Reil G, Granzier H, Kratz M, Kazakov A
Eur Heart J. 2012; 34(36):2839-49.
PMID: 22833515
PMC: 3858102.
DOI: 10.1093/eurheartj/ehs218.